Brian Berry

2.5k total citations · 1 hit paper
27 papers, 1.7k citations indexed

About

Brian Berry is a scholar working on Pathology and Forensic Medicine, Oncology and Internal Medicine. According to data from OpenAlex, Brian Berry has authored 27 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 5 papers in Internal Medicine. Recurrent topics in Brian Berry's work include Lymphoma Diagnosis and Treatment (10 papers), Blood transfusion and management (5 papers) and Viral-associated cancers and disorders (5 papers). Brian Berry is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Blood transfusion and management (5 papers) and Viral-associated cancers and disorders (5 papers). Brian Berry collaborates with scholars based in Canada, United States and United Kingdom. Brian Berry's co-authors include Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn, Mukesh Chhanabhai, Judy Sutherland, Richard Klasa, Karamjit Gill, Paul Hoskins, Kerry J. Savage and Tamara Shenkier and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Brian Berry

26 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

2006 1.0k citations Laurie H. Sehn, Brian Berry et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Berry Canada	15	1.2k	768	411	395	190	27	1.7k
Paolo G. Gobbi Italy	29	1.6k 1.3×	905 1.2×	686 1.7×	432 1.1×	281 1.5×	86	2.6k
R. E. Marcus United Kingdom	18	1.1k 0.9×	979 1.3×	640 1.6×	223 0.6×	224 1.2×	47	1.9k
Pam McKay United Kingdom	21	763 0.6×	443 0.6×	524 1.3×	389 1.0×	78 0.4×	77	1.4k
Rika Sakai Japan	24	581 0.5×	526 0.7×	370 0.9×	196 0.5×	190 1.0×	107	1.5k
Yang Feng China	23	691 0.6×	643 0.8×	146 0.4×	207 0.5×	96 0.5×	75	1.6k
Louis F. Diehl United States	27	1000 0.8×	630 0.8×	1.0k 2.5×	181 0.5×	596 3.1×	85	2.3k
E. Maartense Netherlands	17	576 0.5×	1.3k 1.7×	297 0.7×	143 0.4×	103 0.5×	49	2.0k
M. Gospodarowicz Canada	18	956 0.8×	494 0.6×	168 0.4×	235 0.6×	83 0.4×	28	1.6k
Soon Il Lee South Korea	18	857 0.7×	1.1k 1.4×	141 0.3×	170 0.4×	254 1.3×	60	1.9k
Ho‐Young Yhim South Korea	17	415 0.3×	361 0.5×	203 0.5×	134 0.3×	167 0.9×	116	1.2k

Countries citing papers authored by Brian Berry

Since Specialization

Citations

This map shows the geographic impact of Brian Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Berry more than expected).

Fields of papers citing papers by Brian Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Berry. The network helps show where Brian Berry may publish in the future.

Co-authorship network of co-authors of Brian Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Berry. A scholar is included among the top collaborators of Brian Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Berry. Brian Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armali, Chantal, H. G. Downie, Brian Berry, et al.. (2020). Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017. Vox Sanguinis. 116(2). 225–233.

Boyle, Terry, Joseph M. Connors, Randy D. Gascoyne, et al.. (2017). Physical activity, obesity and survival in diffuse large B‐cell and follicular lymphoma cases. British Journal of Haematology. 178(3). 442–447. 19 indexed citations

Nielsen, Julie S., Aniqa Shahid, Zusheng Zong, et al.. (2015). Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells. Clinical Cancer Research. 22(9). 2226–2236. 18 indexed citations

Berry, Brian, et al.. (2015). Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease. BMC Research Notes. 8(1). 308–308. 8 indexed citations

Berry, Brian, et al.. (2015). Small lymphocytic lymphoma with florid perniosis-like features: a case report. BMC Dermatology. 15(1). 11–11. 2 indexed citations

Schuetz, Johanna M., Denise Daley, Stephen Leach, et al.. (2013). Non-Hodgkin Lymphoma Risk and Variants in Genes Controlling Lymphocyte Development. PLoS ONE. 8(9). e75170–e75170. 9 indexed citations

Bretherick, Karla L., Johanna M. Schuetz, Lindsay M. Morton, et al.. (2013). Sex- and Subtype-Specific Analysis of H2AFX Polymorphisms in Non-Hodgkin Lymphoma. PLoS ONE. 8(9). e74619–e74619. 2 indexed citations

Berrang, Tanya, et al.. (2013). Successful treatment of non‐Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy. Hematological Oncology. 31(4). 218–220. 5 indexed citations

Schuetz, Johanna M., Denise Daley, Jinko Graham, et al.. (2012). Genetic Variation in Cell Death Genes and Risk of Non-Hodgkin Lymphoma. PLoS ONE. 7(2). e31560–e31560. 22 indexed citations

10.

Sehn, Laurie H., David W. Scott, Mukesh Chhanabhai, et al.. (2011). Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP. Journal of Clinical Oncology. 29(11). 1452–1457. 146 indexed citations

11.

Robinson, Simon D., Christian Janßen, Eric Fretz, et al.. (2011). Non-red blood cell transfusion as a risk factor for mortality following percutaneous coronary intervention. International Journal of Cardiology. 157(2). 169–173. 5 indexed citations

12.

Berry, Brian, et al.. (2010). Rituximab for Management of Refractory Pregnancy-Associated Immune Thrombocytopenic Purpura. Journal of Obstetrics and Gynaecology Canada. 32(12). 1167–1171. 29 indexed citations

13.

Robinson, Simon D., Christian Janßen, Eric Fretz, et al.. (2010). Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention. American Heart Journal. 159(5). 876–881. 43 indexed citations

14.

Byrne, Jonathan, Mark S. Spence, Eric Fretz, et al.. (2009). Body Mass Index, Periprocedural Bleeding, and Outcome Following Percutaneous Coronary Intervention (from the British Columbia Cardiac Registry). The American Journal of Cardiology. 103(4). 507–511. 45 indexed citations

15.

Berry, Brian, et al.. (2008). Retrospective Clinical Audit of Adherence to a Protocol for Prophylaxis of Venous Thromboembolism in Surgical Patients. The Canadian Journal of Hospital Pharmacy. 61(3). 3 indexed citations

16.

Wilson, Kenneth S., Laurie H. Sehn, Brian Berry, et al.. (2007). CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma. Leukemia & lymphoma. 48(6). 1102–1109. 46 indexed citations

17.

Spinelli, John J., Carmen Ng, Jean‐Philippe Weber, et al.. (2007). Organochlorines and risk of non‐Hodgkin lymphoma. International Journal of Cancer. 121(12). 2767–2775. 97 indexed citations

18.

Viswanatha, David S., et al.. (2000). Blastic Mantle Cell Leukemia: An Unusual Presentation of Blastic Mantle Cell Lymphoma. Modern Pathology. 13(7). 825–833. 43 indexed citations

19.

Forrest, Donna L., Douglas E. Horsman, Brian Berry, et al.. (1998). Myelodysplastic Syndrome with Hypereosinophilia and a Nonrandom Chromosomal Abnormality dic(1;7). Cancer Genetics and Cytogenetics. 107(1). 65–68. 26 indexed citations

20.

Townsend, G. E., et al.. (1996). Enoxaparin for Unstable Angina and Ancrod for Cardiac Surgery following Heparin Allergy. Annals of Pharmacotherapy. 30(5). 476–480. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact